Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

In search of novel inhibitors of anti-cancer drug target fibroblast growth factor receptors: Insights from virtual screening, molecular docking, and molecular dynamics
A. M. U. B. Mahfuz, Md. Arif Khan, Suvro Biswas, et al.
Arabian Journal of Chemistry (2022) Vol. 15, Iss. 7, pp. 103882-103882
Open Access | Times Cited: 19

Showing 19 citing articles:

Computer-aided drug design in anti-cancer drug discovery: What have we learnt and what is the way forward?
Opeyemi Iwaloye, Paul Olamide Ottu, Femi Olawale, et al.
Informatics in Medicine Unlocked (2023) Vol. 41, pp. 101332-101332
Open Access | Times Cited: 35
Structure-odor relationship in pyrazines and derivatives: A physicochemical study using 3D-QSPR, HQSPR, Monte Carlo, molecular docking, ADME-Tox and molecular dynamics
Mohamed Ouabane, Kamal Tabti, Halima Hajji, et al.
Arabian Journal of Chemistry (2023) Vol. 16, Iss. 11, pp. 105207-105207
Open Access | Times Cited: 16
Structure-based drug-development study against fibroblast growth factor receptor 2: molecular docking and Molecular dynamics simulation approaches
Anas Shamsi, M. S. Khan, Dharmendra Kumar Yadav, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 7
An in silico approach to develop potential therapies against Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
Suvro Biswas, Mohasana Akter Mita, Shamima Afrose, et al.
Heliyon (2024) Vol. 10, Iss. 4, pp. e25837-e25837
Open Access | Times Cited: 3
Targeting human progesterone receptor (PR), through pharmacophore-based screening and molecular simulation revealed potent inhibitors against breast cancer
Muhammad Shahab, Peng Ziyu, Muhammad Waqas, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Plant-derived compounds effectively inhibit the main protease of SARS-CoV-2: An in silico approach
Shafi Mahmud, Shamima Afrose, Suvro Biswas, et al.
PLoS ONE (2022) Vol. 17, Iss. 8, pp. e0273341-e0273341
Open Access | Times Cited: 11
Cell-Free Supernatants (CFSs) from the Culture of Bacillus subtilis Inhibit Pseudomonas sp. Biofilm Formation
Shirmin Islam, Md. Liton Mahmud, Waleed Hassan Almalki, et al.
Microorganisms (2022) Vol. 10, Iss. 11, pp. 2105-2105
Open Access | Times Cited: 11
Biological Efficacy of Compounds from Stingless Honey and Sting Honey against Two Pathogenic Bacteria: An In Vitro and In Silico Study
Shirmin Islam, Mohammad Joy Pramanik, Suvro Biswas, et al.
Molecules (2022) Vol. 27, Iss. 19, pp. 6536-6536
Open Access | Times Cited: 10
Integrated Computational Approaches for Inhibiting Sex Hormone-Binding Globulin in Male Infertility by Screening Potent Phytochemicals
Suvro Biswas, Mohasana Akter Mita, Shamima Afrose, et al.
Life (2023) Vol. 13, Iss. 2, pp. 476-476
Open Access | Times Cited: 5
Modified oxymatrine as novel therapeutic inhibitors against Monkeypox and Marburg virus through computational drug design approaches
Md. Rezaul Islam, Suvro Biswas, Ummy Amena, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 18
Open Access | Times Cited: 1
Discovery of octahydropyrrolo [3,2‐b] pyridin derivative as a highly selective Type I inhibitor of FGFR3 over VEGFR2 by high‐throughput virtual screening
Xin Wang, Cheng‐hao Ye, En‐min Li, et al.
Journal of Cellular Biochemistry (2022) Vol. 124, Iss. 2, pp. 221-238
Closed Access | Times Cited: 4
Effects of gamma-radiation on microbial, nutritional, and functional properties of Katimon mango peels: A combined biochemical and in silico studies
Tabassum Jabin, Suvro Biswas, Shirmin Islam, et al.
Heliyon (2023) Vol. 9, Iss. 11, pp. e21556-e21556
Open Access | Times Cited: 2
Selenicereus undatus (Dragon Fruit) Phytochemicals for Managing Three Human Pathogenic Bacteria: An In Vitro and In Silico Approach
Zhuanying Yang, Xuewen Zheng, Wenhao Jiang, et al.
Metabolites (2024) Vol. 14, Iss. 11, pp. 577-577
Open Access
Virtual Screening, Molecular Dynamics, MM-PBSA and In-silico Studies in Search of Potent Novel Fibroblast Growth Factor Receptors 4 Inhibitor
Fady H Fayek, Omar M. Rashad
Journal of Modern Biology and Drug Discovery (2024) Vol. 3, pp. 2-2
Open Access
Fibroblast growth factor 2 is a druggable target against glioblastoma: A computational investigation
Rabeea Siddique, Syed Ainul Abideen, Ghulam Nabi, et al.
Frontiers in Chemistry (2022) Vol. 10
Open Access | Times Cited: 2
Dataset on In-silico Evaluation of Anti-oxidant Molecules of Talinum triangulare (Jacq.) Willd. in Cerebral Ischemic Disease Using Molecular Docking Studies
G. Bhaskar, M. Nalini, DSNBK Prasanth, et al.
Chemistry Africa (2023) Vol. 6, Iss. 4, pp. 2205-2216
Closed Access
Molecular modeling approach for cancer drug therapy
Bhavini Singh, Rishabh Rege, Ganji Purnachandra Nagaraju
Elsevier eBooks (2023), pp. 11-18
Closed Access
Targeting Human progesterone receptor (PR), through Pharmacophore- based screening and molecular simulation revealed potent inhibitors against breast cancer
Muhammad Shahab, Peng Ziyu, Guojun Zheng, et al.
Research Square (Research Square) (2023)
Open Access
From nature to cancer therapy: Evaluating the Streptomyces clavuligerus secondary metabolites for potential protein kinase inhibitors
Ravi Saini, Sonali Kumari, Amit Singh, et al.
Journal of Cellular Biochemistry (2023) Vol. 125, Iss. 1, pp. 59-78
Closed Access
Page 1

Scroll to top